The recall comes in the wake of concerns over contamination of benzene, news outlet reported. A spokesperson for La ...

Makeup company L’Oréal S.A. has issued a recall on its popular acne cream Effaclar Duo due to concern that benzene, a known carcinogen, is in the product. Last year, independent Connecticut testing ...

In what it says is the biggest obesity deal to date, Zealand Pharma A/S has signed up Roche AG to a potential $5.3 billion global collaboration and license agreement to develop petrelintide, an amylin ...

La Roche-Posay, Walgreens, Proactiv and SLMD Skincare have voluntarily recalled acne treatments from retail that contained ...

Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.

LENTEN DEVOTIONALS FROM HOLY GHOST LUTHERAN ...

The Fredericksburg Art Guild will feature the works of local artist Donna Roche throughout the month of March.

One of the biggest beauty brands issued a voluntary recall for a facial treatment due to concerns that it may contain a ...

The news sent Roche's stock up more than 4% in trading Wednesday, and Zealand's stock skyrocketed 40% on the news. Meanwhile, Novo Nordisk's stock was hit, sliding 4%, and Eli Lilly's stock was down ...

L’Oreal is recalling all remaining units of an acne treatment product that could be contaminated with a cancer-causing chemical, Fortune reports.

European shares rebounded on optimism over developments in the Ukraine-Russia conflict and a cooler U.S. inflation report. A ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...